CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin- conjugating pathway

Journal of Virology

Volumn 72, Issue 3, 1998, Pages 2280-2288

  Schubert, Ulrich ^a   Antón, Luis C ^a   Bačík, Igor ^a   Cox, Josephine H ^a   Bour, Stéphane ^a   Bennink, Jack R ^a   Orlowski, Marian ^b   Strebel, Klaus ^a   Yewdell, Jonathan W ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALNEXIN; CD4 ANTIGEN; PROTEASOME; UBIQUITIN; UBIQUITIN PROTEIN LIGASE; VIRUS PROTEIN;

ARTICLE; CONJUGATION; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INTRACELLULAR TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0031935031     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.3.2280-2288.1998     Document Type: Article

References (66)

1. Aiken, C. J., J. Konner, N. R. Landau, E. Lenburg, and D. Trono. 1994. Nef induces CD4 endocytosis: requirement of a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76:503-513.
2. Anderson, S. J., M. Lenburg, N. R. Landau, and V. J. Garcia. 1994. The cytoplasmic domain of CD4 is sufficient for its down-regulation from the cell surface by human immunodeficiency virus type 1 Nef. J. Virol. 68:3092-3101.
3. Bergeron, J. J. M., M. B. Brenner, D. Y. Thomas, and D. B. Williams. 1994. Calnexin: a membrane bound chaperone of the endoplasmic reticulum. Trends Biochem. Sci. 19:124-128.
4. Bonifacino, J. S., and R. D. Klausner. 1994. Degradation of proteins in the endoplasmic reticulum, p. 137-160. In A. Ciechanover and A. L. Schwartz (ed.), Cellular proteolytic systems, vol. 15. Wiley-Liss, New York, N.Y.
5. Bour, S., F. Boulerice, and M. A. Wainberg. 1991. Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1. J. Virol. 65:6387-6396.
6. Bour, S., U. Schubert, and K. Strebel. 1995. The human immunodeficiency virus type-1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation. J. Virol. 69:1510-1520.
7. Broder, C. C., D. S. Dimitrov, R. Blumenthal, and E. A. Berger. 1993. The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s). Virology 193:483-491.
8. Buonocore, L., and J. K. Rose. 1990. Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum. Nature 345:625-628.
9. Buonocore, L., T. G. Turi, B. Crise, and J. K. Rose. 1994. Stimulation of heterologous protein degradation by the Vpu protein of HIV-1 requires the transmembrane and cytoplasmic domains of CD4. Virology 204:482-486.
10. Chakrabarti, S., K. Brechling, and B. Moss. 1985. Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5:3403-3409.
11. Chen, M. Y., F. Maldarelli, M. K. Karczewski, R. L. Willey, and K. Strebel. 1993. Human immunodeficiency virus type 1 Vpu protein induces degradation of CD4 in vitro: the cytoplasmic domain of CD4 contributes to Vpu sensitivity. J. Virol. 67:3877-3884.
12. Coben, E. A., E. F. Terwilliger, J. G. Sordroski, and W. A. Haseltine. 1988. Identification of a protein encoded by the vpu gene of HIV-1. Nature 334:532-534.
13. 1 ubiquitin-activating enzyme in temperature-sensitive cell lines. J. Immunol. 154:511-519.
14. Crise, B., L. Buonocore, and J. K. Rose. 1990. CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor. J. Virol. 64:5585-5593.
15. Deen, K. C., J. S. McDougal, R. Inacker, G. Folena-Wasserman, J. Arthos, J. Rosenberg, P. Maddon, J. R. Axel, and R. W. Sweet. 1988. A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Nature 331:82-84.
16. Eckert, D. J., M. I. Khan, J. Marsh, T. R. Butt and S. T. Crooke. 1987. Chemical synthesis and expression of a cassette adapted ubiquitin gene. J. Biol. Chem. 262:3524-3527.
17. Eisenlohr, L. C., I. Bacik, J. R. Bennink, K. Bernstein, and J. W. Yewdell. 1992. Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T lymphocytes. Cell 71:963-972.
18. Eleuteri, A. M., R. A. Kohanski, C. Cardozo, and M. Orlowski. 1997. Bovine spleen multicatalytic proteinase complex (proteasome); replacement of X, Y, and Z subunits by LMP7, and MECL1 and changes in properties and specificity. J. Biol. Chem. 272:11824-11831.
19. Ewart, G. D., T. Sutherland, P. W. Gage, and G. B. Cox. 1996. The Vpu protein of human immunodeficiency virus type 1 forms cation-selective ion channels. J. Virol. 70:7108-7115.
20. Federau, T., U. Schubert, J. Floßdorf, P. Henklein, D. Schomburg, and V. Wray. 1996. Solution structure of the cytoplasmic domain of the human immunodeficiency virus type 1 encoded virus protein U (Vpu). Int. J. Peptide Protein Res. 47:297-310.
21. Fenteany, G., R. F. Standaert, W. S. Lane, S. Choi, E. J. Corey, and S. L. Schreiber. 1995. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystein. Science 268:726-731.
22. Finley, D., S. Sadis, B. P. Monia, P. Boucher, D. J. Ecker, S. T. Crooke, and V. Chau. 1994. Inhibition of proteolysis and cell cycle progression in a multiubiquitination-deficient yeast mutant. Mol. Cell. Biol. 14:5501-5509.
23. Folks, T., S. Benn, A. Rabson, T. Theodore, D. Hoggan, M. A. Martin, M. Lightfoot, and K. Sell. 1985. Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus. Proc. Natl. Acad. Sci. USA 8:4539-4543.
24. Fujita, K., S. Omura, and J. Silver. 1997. Rapid degradation of CD4 in cells expressing human immunodeficiency virus type 1 Env and Vpu is blocked by proteasome inhibitors. J. Gen. Virol. 78:619-625.
25. Hiller, M. M., A. Finger, M. Schweiger, and D. H. Wolf. 1996. ER degradation of a misfolded luminal protein by the cytosolic ubiquitin-proteasome pathway. Science 273:1725-1728.
26. Howell, D. N., P. E. Andreotti, J. R. Dawson, and P. Cresswell. 1985. Natural killing target antigens as inducers of interferon: studies with an immunoselected, natural killing-resistant human T lymphoblastoid cell line. J. Immunol. 134:971-976.
27. Jensen, T. J., M. A. Loo, S. Pind, D. B. Williams, A. L. Goldberg, and J. R. Riordan. 1995. Multiple proteolytic system, including the proteasome, contribute to CFTR processing. Cell 83:129-135.
28. Kerkau, T., I. Bacik, J. Yewdell, J. R. Bennink, T. Hünig, A. Schimpl, and U. Schubert. 1997. The human immunodeficiency virus type-1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules. J. Exp. Med. 185:1295-1305.
29. Klimkait, T., K. Strebel, M. D. Hoggan, M. A. Martin, and J. M. Orenstein. 1990. The human immunodeficiency virus type 1-specific protein Vpu is required for efficient virus maturation and release. J. Virol. 64:621-629.
30. Köning, R., S. Fleury, and R. N. Germain. 1996. The structural basis of CD4-MHC class II interactions: co-receptor contributions to T cell receptor antigen recognition and oligomerization-dependent signal transduction. Curr. Top. Microbiol. Immunol. 205:19-46.
31. Lamb, R. A., and L. H. Pinto. 1997. Do Vpu and Vpr of human immuno-deficiency virus type 1 and NB of influenza B virus have ion channel activities in the viral life cycles? Virology 229:1-11.
32. Le, A., J. L. Steiner, G. A. Ferrell, J. C. Shaker, and R. N. Sifers. 1994. Association between calnexin and a secretion-incompetent variant of human a1-antitrypsin. J. Biol. Chem. 269:7514-7519.
33. Lee, D. H., and A. L. Goldberg. 1996. Selective inhibitors of the proteasome-dependent and vacuolar pathways of protein degradation in Saccharomyces cerevisiae. J. Biol. Chem. 271:272800-27284.
34. Lenburg, M. E., and N. R. Landau. 1993. Vpu-induced degradation of CD4: requirement of specific amino acid residues in the cytoplasmic domain of CD4. J. Virol. 67:7238-7245.
35. Maldarelli, F., M. Y. Chen, R. L. Willey, and K. Strebel. 1993. Human immunodeficiency virus type 1 Vpu protein is an oligomeric type 1 integral membrane protein. J. Virol. 67:5056-5061.
36. McCracken, A. A., and J. F. Brodsky. 1996. Assembly of ER-associated protein degradation in vitro: dependence of cytosol, calnexin, and ATP. J. Cell Biol. 132:291-298.
37. Nandi, D., and J. J. Monaco. 1995. The genetics of proteasomes and antigen processing. Annu. Rev. Genet. 29:729-754.
38. Orlowski, M., C. Cardozo, and C. Michaud. 1993. Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids. Biochemistry 23:1563-1572.
39. Palmer, A., A. J. Rivett, S. Thomson, K. B. Hendil, G. W. Butcher, G. Fuertes, and E. Knecht. 1996. Subpopulations of proteasomes in rat liver nuclei, microsomes and cytosol. Biochem. J. 316:401-407.
40. Phillips, D. M., and A. S. Bourinbaiar. 1992. Mechanism of HIV spread from lymphocytes to epithelia. Virology 86:261-273.
41. Pind, S., J. R. Riordan, and D. B. Williams. 1994. Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 269:12784-12788.
42. Qu, D., J. H. Teckman, S. Omura, and D. H. Perlmutter. 1996. Degradation of a mutant secretory protein, alpha1-antitrypsin Z. in the endoplasmic reticulum requires proteasome activity. J. Biol. Chem. 271:22791-22795.
43. Sadasivan, B., P. J. Lehner, B. Ortmann, T. Spies, and P. Cresswell. 1996. Roles of calreticulin and novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 5:103-114.
44. Schneider, C., R. A. Newman, D. R. Sutherland, U. Asser, and M. F. Greaves. 1982. A one-step purification of membrane proteins using a high efficiency immunomatrix. J. Biol. Chem. 257:10766-10769.
45. Schubert, U., S. Bour, A. F. Ferrer-Montiel, M. Montal, F. Maldarelli, and K. Strebel. 1996. The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. J. Virol. 70:809-819.
46. Schubert, U., K. A. Clouse, and K. Strebel. 1995. Augmentation of virus secretion by the HIV-1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes. J. Virol. 69:7699-7711.
47. Schubert, U., A. F. Ferrer-Montiel, M. Oblatt-Montal, P. Henklein, K. Strebel, and M. Montal. 1996. Identification of an ion channel activity of the Vpu transmembrane domain and its plausible involvement in the regulation of virus release from HIV-1-infected cells. FEBS Lett. 398:12-18.
48. 56 within a predicted α-helix-turn-α-helix-motif. J. Mol. Biol. 236:16-25.
49. Schubert, U., T. Schneider, P. Henklein, K. Hoffmann, E. Berthold, H. Hauser, G. Pauli, and T. Porstmann. 1992. Human-immunodeficiency-virus-type-1-encoded Vpu protein is phosphorylated by casein kinase II. Eur. J. Biochem. 204:875-883.
50. Schubert, U., and K. Strebel. 1994. Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments. J. Virol. 68:2260-2271.
51. Strebel, K., T. Klimkait, and M. A. Martin. 1988. A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science 241:1221-1223.
52. Strebel, K., T. Klimkait, F. Maldarelli, and M. A. Martin. 1989. Molecular and biochemical analyses of human immunodeficiency virus type 1 Vpu protein. J. Virol. 63:3784-3791.
53. Tifft, C. J., R. L. Proia, and R. D. Camerini-Otero. 1992. The folding and cell surface expression of CD4 requires grycosylation. J. Biol. Chem. 267:3266-3273.
54. Townsend, A., J. Bastin, G. Keith, G. Brownlee, M. Andrew, B. Coopar, D. Boyle, S. Chan, and G. Smith. 1988. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J. Exp. Med. 168:211-1224.
55. Trono, D. 1994. HIV accessory proteins: leading roles for the supporting cast. Cell 82:189-192.
56. Tsubuki, S., Y. Saito, M. Tomioka, I. Hisashi, and S. Kawashíma. 1996. Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine. J. Biochem. 11:572-576.
57. Varshavsky, A. 1992. The N-end rule. Cell 69:725-735.
58. Vinitsky, A., L. C. Antón, H. Link-Snyder, M. Orlowski, J. R. Bennink, and J. W. Yewdell. The generation of MHC class I associated peptides is only partially inhibited by proteasome inhibitors: involvement of non-proteasomal proteases in antigen processing? J. Immunol., in press.
59. Vinitsky, A., C. Michaud, J. C. Powers, and M. Orlowski. 1992. Inhibition of the chymotrypsin-like activity of the pituitary multicatalytic proteinase complex. Biochemistry 31:9421-9428.
60. Ward, C. L., S. Omura, and R. R. Kopito. 1995. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83:121-127.
61. Wiertz, E. J. H. J., T. R. Jones, L. Sun, M. Bogyo, H. J. Geuze, and H. L. Ploegh. 1996. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum of the cytosol. Cell 84:769-779.
62. Wiertz, E. J. H. J., D. Tortorella, M. Bogyo, J. Yu, W. Mothes, T. R. Jones, T. A. Rapoport, and H. L. Ploegh. 1996. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteosome for destruction. Nature 384:432-438.
63. Willey, R. L., F. Maldarelli, M. A. Martin, and K. Strebel. 1992. Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes. J. Virol. 66:226-234.
64. Willey, R. L., F. Maldarelli, M. A. Martin, and K. Strebel. 1992. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J. Virol. 66:7193-7200.
65. Wray, V., T. Federau, P. Henklein, S. Klabunde, O. Kunert, D. Schomburg, and U. Schubert. 1995. The solution structure of the hydrophilic region of the HIV-1 encoded virus protein U (Vpu) by CD and NMR spectroscopy. Int. J. Peptide Protein Res. 45:35-43.
66. Zacksenhaus, E., and R. Sheinin. 1990. Molecular cloning, primary structure and expression of the human X linked A1S9 gene cDNA which complements the ts A1S9 mouse L cell defect in DNA replication. EMBO J. 9:2923-2929.